These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 9356013
21. Vanadate augments insulin-stimulated insulin receptor kinase activity and prolongs insulin action in rat adipocytes. Evidence for transduction of amplitude of signaling into duration of response. Fantus IG, Ahmad F, Deragon G. Diabetes; 1994 Mar; 43(3):375-83. PubMed ID: 7508873 [Abstract] [Full Text] [Related]
22. Evidence for the distinct vanadyl(+4)-dependent activating system for manifesting insulin-like effects. Li J, Elberg G, Crans DC, Shechter Y. Biochemistry; 1996 Jun 25; 35(25):8314-8. PubMed ID: 8679588 [Abstract] [Full Text] [Related]
23. Activation of MAP kinase by insulin and vanadate in adipocytes from young and old rats. Molero JC, Pérez C, Martínez C, Villar M, Andrés A, Fermín Y, Carrascosa JM. Mol Cell Endocrinol; 2002 Mar 28; 189(1-2):77-84. PubMed ID: 12039066 [Abstract] [Full Text] [Related]
24. Peroxovanadate induces tyrosine phosphorylation of phosphoinositide-dependent protein kinase-1 potential involvement of src kinase. Grillo S, Grémeaux T, Casamayor A, Alessi DR, Le Marchand-Brustel Y, Tanti JF. Eur J Biochem; 2000 Nov 28; 267(22):6642-9. PubMed ID: 11054117 [Abstract] [Full Text] [Related]
32. Insulin-like actions of vanadate are mediated in an insulin-receptor-independent manner via non-receptor protein tyrosine kinases and protein phosphotyrosine phosphatases. Shechter Y, Li J, Meyerovitch J, Gefel D, Bruck R, Elberg G, Miller DS, Shisheva A. Mol Cell Biochem; 1992 Jul 15; 153(1-2):39-47. PubMed ID: 8927046 [Abstract] [Full Text] [Related]